Vemtoberant
| CAS No. | 2169905-68-2 | Cat. No. | BCP49263 |
| Name | Vemtoberant | ||
| Synonyms | APD418; APD 418; APD-418; | ||
| Formula | C29H37N3O8S2 | M. Wt | 619.75 |
| Description | Vemtoberant is a β3-adrenergic receptor (AdrR) antagonist for treatment of decompensated heart failure. Unlike current inotrope therapies, Vemtoberant improves cardiac contractility with minimal negative impact on heart rate, blood pressure, and myocardial oxygen consumption. Vemtoberant has undergone Phase 2 trials for those in heart failure with reduced ejection fraction. | ||
| Pathways | Neuro Signaling Pathway GPCR/G Protein | ||
| Targets | Adrenergic Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.